Fig. 6: Clinical trial simulations and parasite-killing rates in cabamiquine-resistant parasites. | Nature Communications

Fig. 6: Clinical trial simulations and parasite-killing rates in cabamiquine-resistant parasites.

From: Towards clinically relevant dose ratios for Cabamiquine and Pyronaridine combination using P. falciparum field isolate data

Fig. 6

Distribution of the apparent killing rate against a cabamiquine-resistant P. falciparum strain at 24 h (upper panel) and 96 h (lower panel) from clinical trial simulations using a single dose of cabamiquine and pyronaridine; percentage in label: virtual patients exceeding a killing rate of 90% (dashed line); box: 25th to 75th percentile (interquartile range) with median (black horizontal line); whiskers: 1.5 times interquartile range below 25th or above 75th percentile, respectively; dots: values outside whiskers’ range; n = 1000 simulations for each dosing scenario.

Back to article page